Recombinant Human BTLA Fc Chimera (aa 31-153) Protein, CF Summary
Product Specifications
| Human BTLA (Lys31-Trp153) Accession # Q7Z6A9-1 | IEGRMD | Human IgG1 (Pro100-Lys330) |
| N-terminus | C-terminus | |
Analysis
Product Datasheets
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
9509-BT
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
| Reconstitution | Reconstitute at 500 μg/mL in PBS. |
| Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Scientific Data
View Larger
When Recombinant Mouse HVEM/TNFRSF14 Fc Chimera (Catalog # 2516-HV) is coated at 0.5 µg/mL (100 µL/well), Recombinant Human BTLA Fc Chimera (Catalog # 9509-BT) binds with an ED50 of 15-90 ng/mL.
Reconstitution Calculator
Background: BTLA
B- and T- lymphocyte attenuator (BTLA), also known as B- and T-lymphocyte-associated protein and CD272, is a type I transmembrane glycoprotein that belongs to the CD28 family of T cell co-stimulatory molecules (1-3). Mature human BTLA contains a 127 amino acid (aa) extracellular domain (ECD), a 21 aa transmembrane domain, and a 111 aa cytoplasmic domain. The ECD of human BTLA shares 42% and 44% aa identity with mouse and rat BTLA, respectively. Unlike other CD28 family members, the BTLA Ig domain in the ECD is of the I-type rather than V-type (4). BTLA is expressed on T cells, B cells, macrophages, dendritic cells and NK cells (5). BTLA is also unusual in its interaction with the TNF superfamily member HVEM rather than with B7 family ligands (6). Its expression is low in naïve T cells and increases during antigen-specific induction of anergy. BTLA apparently limits T cell numbers, since its deletion results in overproduction of T cells, especially CD8+ memory T cells that are hyper-responsive to TCR cross-linking (7). Under the control of ROR gamma t and IL-7, BTLA regulates the homeostasis and inflammatory responses of gamma δT cells (8). The binding of BTLA and HVEM does not preclude the concurrent binding of other HVEM ligands such as LIGHT or Lymphotoxin‑alpha (10).
- Murphy, K.M. et al. (2006) Nat. Rev. Immunol. 6:671.
- Croft, M. (2005) Trends. Immunol. 26:292.
- Watannabe, N. et al. (2003) Nat. Immunol. 4:670.
- Compaan, D.M. et al. (2005) J. Biol. Chem. 280:39553.
- Hurchia, M.A. et al. (2005) J. Immunol. 174:3377.
- Sedy, J. R. et al. (2005) Nat. Immunol. 6:90.
- Krieg, C. et al. (2007) Nat. Immunol. 8:162.
- Bekiaris, V. et al. (2013) Immunity 39:1082.
- Gavrieli, M. et al. (2003) Biochem. Biophys. Res. Commun. 312:1236.
- Cai G and Freeman GJ, (2009) Immunol Rev. 229:244
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Human BTLA Fc Chimera (aa 31-153) Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Human BTLA Fc Chimera (aa 31-153) Protein, CF and earn rewards!
Have you used Recombinant Human BTLA Fc Chimera (aa 31-153) Protein, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
